Open access · CC-BY
via OpenAlex
Amyloid Beta in Aging and Alzheimer’s Disease
Ujala Sehar, Priyanka Rawat, Arubala P. Reddy, Jonathan J. Kopel, P. Hemachandra Reddy
International Journal of Molecular Sciences · 2022 · ▲ 362 citations
Abstract
Alzheimer's disease (AD), is a progressive neurodegenerative disease that affects behavior, thinking, learning, and memory in elderly individuals. AD occurs in two forms, early onset familial and late-onset sporadic; genetic mutations in PS1, PS2, and APP genes cause early onset familial AD, and a combination of lifestyle, environment and genetic factors causes the late-onset sporadic form of the disease. However, accelerated disease progression is noticed in patients with familial AD. Disease-causing pathological changes are synaptic damage, and mitochondrial structural and functional changes, in addition to increased production and accumulation of phosphorylated tau (p-tau), and amyloid beta (Aβ) in the affected brain regions in AD patients. Aβ is a peptide derived from amyloid precursor protein (APP) by proteolytic cleavage of beta and gamma secretases. APP is a glycoprotein that plays a significant role in maintaining neuronal homeostasis like signaling, neuronal development, and intracellular transport. Aβ is reported to have both protective and toxic effects in neurons. The purpose of our article is to summarize recent developments of Aβ and its association with synapses, mitochondria, microglia, astrocytes, and its interaction with p-tau. Our article also covers the therapeutic strategies that reduce Aβ toxicities in disease progression and discusses the reasons for the failures of Aβ therapeutics.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/ijms232112924
- Canonical
- link ↗
- Fetched
- 2026-10-03 MST
Cite this
APA
Sehar, U., Rawat, P., Reddy, A.P., Kopel, J.J., & Reddy, P.H. (2022). Amyloid Beta in Aging and Alzheimer’s Disease. <em>International Journal of Molecular Sciences</em>. https://doi.org/10.3390/ijms232112924
Vancouver
Sehar U, Rawat P, Reddy AP, Kopel JJ, Reddy PH. Amyloid Beta in Aging and Alzheimer’s Disease. International Journal of Molecular Sciences. 2022. doi:10.3390/ijms232112924.
BibTeX
@article{ujala2022Amyloi,
title = {Amyloid Beta in Aging and Alzheimer’s Disease},
author = {Ujala Sehar and Priyanka Rawat and Arubala P. Reddy and Jonathan J. Kopel and P. Hemachandra Reddy},
journal = {International Journal of Molecular Sciences},
year = {2022},
doi = {10.3390/ijms232112924},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Aging Cell 2004
Citation only
How chronic inflammation can affect the brain and support the development of Alzheimer's disease in old age: the role of microglia and astrocytes
Journal of Neurochemistry 2019
Open access · OA
Microglia and the aging brain: are senescent microglia the key to neurodegeneration?
Biomedicine & Pharmacotherapy 2022
Open access · CC-BY
Are mitophagy enhancers therapeutic targets for Alzheimer’s disease?
International journal of research and scientific innovation 2026
Citation only
Chronological Versus Biological Age: The Role of Diet and Healthy Lifestyle in Modulating Epigenetic Aging
Neurology 1998
Citation only
Alzheimer's disease
medRxiv 2020
Preprint · CC-BY